Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 24:14:10351-10372.
doi: 10.2147/IJGM.S339475. eCollection 2021.

Recent Advancements on COVID-19: A Comprehensive Review

Affiliations
Review

Recent Advancements on COVID-19: A Comprehensive Review

Heshu Sulaiman Rahman et al. Int J Gen Med. .

Abstract

Over the last few decades, there have been several global outbreaks of severe respiratory infections. The causes of these outbreaks were coronaviruses that had infected birds, mammals and humans. The outbreaks predominantly caused respiratory tract and gastrointestinal tract symptoms and other mild to very severe clinical signs. The current coronavirus disease-2019 (COVID-19) outbreak, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a rapidly spreading illness affecting millions of people worldwide. Among the countries most affected by the disease are the United States of America (USA), India, Brazil, and Russia, with France recording the highest infection, morbidity, and mortality rates. Since early January 2021, thousands of articles have been published on COVID-19. Most of these articles were consistent with the reports on the mode of transmission, spread, duration, and severity of the sickness. Thus, this review comprehensively discusses the most critical aspects of COVID-19, including etiology, epidemiology, pathogenesis, clinical signs, transmission, pathological changes, diagnosis, treatment, prevention and control, and vaccination.

Keywords: COVID-19; a comprehensive review; global outbreak; pandemic infection; recent advancements.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest related to this work/review article.

Figures

Figure 1
Figure 1
Pathophysiology of COVID-19 indicate virus entering the host cells through interaction of its spike protein with the entry receptor ACE2 in the presence of TMPRSS2.

References

    1. Lai -C-C, Liu YH, Wang C-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53(3):404–412. doi:10.1016/j.jmii.2020.02.012 - DOI - PMC - PubMed
    1. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–286. doi:10.1007/s12098-020-03263-6 - DOI - PMC - PubMed
    1. Heneghan C, Brassey J, Jefferson T. COVID-19: what proportion are asymptomatic? The Centre for Evidence-Based Medicine; 2020. Available from: https://www.cebm.net/covid-19/covid-19-what-proportion-are-asymptomatic/. Accessed November 30, 2021.
    1. Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016/j.ijantimicag.2020.105949 - DOI - PMC - PubMed
    1. Tian X, Li C, Huang A, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020;9(1):382–385. doi:10.1080/22221751.2020.1729069 - DOI - PMC - PubMed